We synthesized 7-substituted-3-(2,4-dinitrostyryl)cephalosporin derivatives which were Nitrocefin analogs, for detecting extended spectrum blactamase (ESBL) specifically. HMRZ-86 which has carboxypropyloxyimino group on 7-aminothiazolacetamide substituent were not hydrolyzed by class A, C and D blactamases, but it was hydrolyzed by ESBL and metallo blactamase (class B), then its color changed from yellow to red. The hydrolysis of metallo b-lactamase was inhibited by adding sodium mercapto acetic acid (SMA). Therefore HMRZ-86 is a useful chromogenic agent to detect ESBL specifically.
hydrolysis of b-lactamase [4, 5] .
In this paper, we outline a synthesizing procedure of the HMRZ-86 and similar compounds, and also biochemical reaction of those compounds for several b-lactamases.
Mechanisms
The HMRZ-86 has a carboxypropyloxyimino group bonded to 7-aminothiazole acetamide to protect the b-lactam ring from b -lactamase, but not from mutated them such as ESBL or metallo b-lactamase. Hydrolysis of the b-lactam ring by these enzymes changes the wavelength absorbed by the conjugated double bond located at position 3, and shifting the color of the compound from yellow to red.
Synthesis of Chromogenic Cephalosporin
Scheme 1 shows sketch of synthesizing process for HMRZ-86 and similar compounds. Here "R" can be replaced substitutes "a" to "d" depending on compound, and substitute of HMRZ-86 is "a". A typical example of a synthesis procedure of HMRZ-86 is given here. At first 7-aminochloromethylcephalosporanic acid benzhydryl ester (1) with (Z )-2-(2-tritylaminothiazol-4-yl)-2-(1-tertbutoxycarbonyl-1-methyl)ethoxyimino acetic acid was amided using dicyclohexylcarbodiimide (DCC) and then (7R)-7-[(Z )-2-(1-methyl-1-tert-butoxycarbonylethoxyimino)-2-(2-tritylaminothiazol-4-yl)acetamido-3-chloromethyl-3-cephem-4-carboxylic acid benzhydryl ester (2a) was synthesized. Next, the compound was treated with NaI and triphenylphosphine for 1.5 hours in acetone, and then evaporated. After the evaporation, the residue was dissolved in dichloromethane-water, then 2,4-dinitrobenzaldehyde and sodium hydrogen carbonate (NaHCO 3 ) were added serially. And the mixture was stirred at room temperature for 1 day and the organic phase was recovered, and concentrated. After concentration, the crude compounds were separated by column chromatography using hexane-ethyl acetate and resulting 3-dinitrostyrylcephem (3a). Protective group of the compound was removed by treatment with trifluoroacetic acid in the presence of anisole, then crude product was recrystallized from 70% acetonitrile to give ( Similarly, other chromogenic cephalosporins were synthesized using starters which position "R" is replaced as "b" to "d" groups.
Materials and Methods

1) Chromogenic Cephalosporin Solutions
1.25 mg of each synthesized compound was dissolved in 0.1 ml of dimethylsulfoxide (DMSO) and diluted to 1 ml by phosphate buffer (0.1 M, pH 7.0).
2) Chromogenic Cephalosporin/Sodium Mercapto
Acetic Acid (SMA)
1.25 mg of SMA is added to each chromogenic cephalosporin solution.
3) Discs
Each 8 ml or 16 ml of diluted solution was added to 8 mm of paper discs, and dried for 30 minutes at 37°C. Finally the disc contained 10 or 20 m g of each chromogenic compound.
4) Strains
Characteristics of the tested strains and enzyme types are shown in Table 1 . These strains were cultivated over night at 37°C on tryptone soy agar (Oxoid Ltd.) containing 2 mg/l of ceftazidime.
5) Minimum Inhibitory Concentration (MICs)
MICs were determined by broth microdilution testing method which was recommended by NCCLS [3] . Table 1 summarizes the antibacterial activities of the synthesized compound. All compounds were active against b -lactamase non-producing S. aureus and E. coli and penicillinase producing S. aureus and K. pneumoniae. However, all compounds were not active against other blactamases, including ESBL, producing strains. Fig. 2 shows the reaction of the compounds with several mutated b -lactamases and ESBLs producing microorganisms. Ten or 20 mg of the compounds were enough to identify the result according to a color change. Nitrocefin reacted with most of these b -lactamases. The compound (4a) which has carboxypropyloxyimino group as protected group for b-lactam ring reacted with ESBL, followed by a strong color change from yellow to red, and with metallo b -lactamases weakly, however it did not react with penicillinase, cephalosporinase and oxacillinase. Other compound (4c) has methoxyimino group and 4d has hydroxyimino group both of which reacted with ESBL and metallo b-lactamases and changing the color similarly to a case of 4a, however, the two compounds 4c and 4d also reacted with penicillinase from Stapylococcus aureus and Scheme 1 cephalosporinase weakly. Compound 4b that does not have oxyimino group reacted with all b-lactamases and a color was changed to red. Subsequently, we investigated whether it is possible to distinguish metallo b -lactamases from ESBL by sodium mercapto acetic acid (SMA). Metallo blactamases is inhibited by chelating agent such as EDTA or SMA, and according to Hanaki [4, 5] , the inhibition of metallo b -lactamases of SMA was stronger than EDTA. And all compounds were escaped from the action of metallo b-lactamases in the presence of SMA. In the tests, it was confirmed that the compound which has alkoxyimino group inhibited b -lactamases but the 4a which has carboxypropyloxyimino group showed the best specificity for ESBL and mutant b-lactamases and that the compound can be applied to differentiate metallo b-lactamase from the other b-lactamases by use of SMA. Now, we are providing simple strip test for screening ESBL and metallo b -lactamase from traditional penicillinase and cephalosporinase, and we believe that those kinds of test kits are useful in routine work in laboratory. 
Results and Discussion
